Meeting to be held in Denver on September 25 hosted by Craig-Hallum.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LGND:
- Jefferies biotech analyst holds an analyst/industry conference call
- Ligand, Travere Therapeutics receives full FDA approval for Filspari
- Ligand price target raised to $110 from $95 at Benchmark
- Ligand sees FY24 revenue $140M-$157M, consensus $147.17M
- Ligand reports Q2 adjusted EPS $1.40, consensus $1.06
Questions or Comments about the article? Write to editor@tipranks.com